November 6, 2019
Takeda Pharmaceutical’s post-Shire-buyout debt-repayment efforts continue. The company said on November 5 that it is selling a portfolio of select OTC and non-core assets sold in Russia and former Soviet states to Germany’s Stada Arzneimittel for US$660 million, with the...read more